Fat around organs and heart as risk markers
Part of Heart & circulation clinical trials.
This study looks at how fat around your organs (visceral fat) and around your heart (epicardial fat) relates to early signs of heart and liver problems. By measuring these fat stores and blood markers, researchers hope to better predict who is at risk for future heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are an outpatient at the Gemelli hospital for a regular check-up or prevention visit.
- You are willing to have an extra blood draw to look for markers of inflammation and metabolism.
- You are willing to have a liver elastography (FibroScan), a quick, painless scan to check liver stiffness.
- You have not had a heart attack, stroke, or related procedures, and you do not have peripheral artery disease.
- You do not have chronic infections, active cancer (within the last 5 years), or conditions like rheumatoid arthritis or lupus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study looks at fat tissue around the heart and how it relates to metabolic health (blood sugar, cholesterol, weight) in people aged 50–70. Researchers will use ultrasound imaging to measure this fat and understand its connection to heart disease risk.
This study looks at how certain blood tests (liver biomarkers) change in people with higher risk for liver disease. It may help doctors understand who is developing liver problems earlier and what patterns in blood tests matter most.
This study tests what happens to the liver and fat metabolism when you eat extra fat for a short time. It may help researchers understand how diet affects liver function and metabolism in otherwise stable adults.
This study aims to find a simple way to detect liver fibrosis, a condition where the liver becomes scarred, in people who have risk factors like being overweight, having type 2 diabetes, or drinking alcohol heavily. By identifying fibrosis early, it may help prevent more serious liver problems.
This study looks at whether simple blood tests can help predict liver scarring (fibrosis) in people with fatty liver disease. If you join, you'll have a quick, non-invasive scan of your liver to check for fat and scarring.
Hear when a new Subclinical Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.